Randomised comparison of ondansetron plus dexamethasone with dexamethasone alone for the control of delayed cisplatin-induced emesis

By Tsukada H.   Hirose T.   Yokoyama A.   Kurita Y.  

European Journal of Cancer, Vol. 37, Iss. 18, 2001-12 ,pp. : 2398-2404

Elsevier

Access to resources Recommend Favorite

Tropisetron, Ondansetron, and Granisetron for Control of Chemotherapy-Induced Emesis in Turkish Cancer Patients: A Comparison of Efficacy, Side-Effect Profile, and Cost

By Abali Huseyin   Celik Ismail  

Cancer Investigation, Vol. 25, Iss. 3, 2007-04 ,pp. : 135-139

Informa Healthcare

Access to resources Recommend Favorite

Oral Ondansetron in the Prevention of Chemotherapy-induced Emesis in Breast Cancer Patients

By Clavel M.   Bonneterre J.   d'Allens H.   Paillarse J.-M.  

European Journal of Cancer, Vol. 31, Iss. 1, 1995-01 ,pp. : 15-19

Elsevier

Access to resources Recommend Favorite

Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis

By Cocquyt V.   Van Belle S.   Reinhardt R.R.   Decramer M.L.A.   O'Brien M.   Schellens J.H.M.   Borms M.   Verbeke L.   Van Aelst F.   De Smet M.   Carides A.D.   Eldridge K.   Gertz B.J.  

European Journal of Cancer, Vol. 37, Iss. 7, 2001-05 ,pp. : 835-842

Elsevier

Access to resources Recommend Favorite

An Open Randomised Cross-over Study on Granisetron Versus Ondansetron in the Prevention of Acute Emesis Induced by Moderate Dose Cisplatin-containing Regimens

By Martoni A.   Angelelli B.   Guaraldi M.   Strocchi E.   Pannuti F.  

European Journal of Cancer, Vol. 32, Iss. 1, 1996-01 ,pp. : 82-85

Elsevier

Access to resources Recommend Favorite